Correlation Between OptiNose and Connect Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both OptiNose and Connect Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OptiNose and Connect Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between OptiNose and Connect Biopharma Holdings, you can compare the effects of market volatilities on OptiNose and Connect Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OptiNose with a short position of Connect Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of OptiNose and Connect Biopharma.

Diversification Opportunities for OptiNose and Connect Biopharma

0.49
  Correlation Coefficient

Very weak diversification

The 3 months correlation between OptiNose and Connect is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding OptiNose and Connect Biopharma Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Connect Biopharma and OptiNose is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OptiNose are associated (or correlated) with Connect Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Connect Biopharma has no effect on the direction of OptiNose i.e., OptiNose and Connect Biopharma go up and down completely randomly.

Pair Corralation between OptiNose and Connect Biopharma

Given the investment horizon of 90 days OptiNose is expected to under-perform the Connect Biopharma. In addition to that, OptiNose is 1.26 times more volatile than Connect Biopharma Holdings. It trades about -0.14 of its total potential returns per unit of risk. Connect Biopharma Holdings is currently generating about -0.04 per unit of volatility. If you would invest  129.00  in Connect Biopharma Holdings on September 3, 2024 and sell it today you would lose (23.00) from holding Connect Biopharma Holdings or give up 17.83% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

OptiNose  vs.  Connect Biopharma Holdings

 Performance 
       Timeline  
OptiNose 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days OptiNose has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Connect Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Connect Biopharma Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

OptiNose and Connect Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with OptiNose and Connect Biopharma

The main advantage of trading using opposite OptiNose and Connect Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OptiNose position performs unexpectedly, Connect Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Connect Biopharma will offset losses from the drop in Connect Biopharma's long position.
The idea behind OptiNose and Connect Biopharma Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules